Cognitive impairment in spontaneously hypertensive rats: Role of central nicotinic receptors. Part II

Brain Research

Volumn 771, Issue 1, 1997, Pages 104-114

  Gattu, Mahanandeeshwar ^a   Terry Jr , Alvin V ^a,b   Pauly, James R ^a   Buccafusco, Jerry J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Autoradiography; Learning and memory; Nicotinic receptor; Passive avoidance; Rubidium efflux; Spontaneously hypertensive rat; Water maze

Indexed keywords

CYTISINE; HYDRALAZINE; NICOTINIC RECEPTOR; RUBIDIUM 86; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; COGNITIVE DEFECT; CONTROLLED STUDY; FRONTAL CORTEX; HYPERTENSION; INTERPEDUNCULAR NUCLEUS; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBICULUM; SYNAPTOSOME; TASK PERFORMANCE; THALAMUS;

AGING; ALKALOIDS; ANIMALS; AVOIDANCE LEARNING; AZOCINES; BINDING SITES; BLOOD PRESSURE; BRAIN; COGNITION DISORDERS; HYPERTENSION; MALE; MAZE LEARNING; QUINOLIZINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; RECEPTORS, NICOTINIC; RUBIDIUM; RUBIDIUM RADIOISOTOPES; TIME FACTORS;

EID: 0030664205     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00794-4     Document Type: Article

References (49)

1. Andersson K., Post B. Effects of cigarette smoking on verbal note learning and physiological arousal. Scand. J. Psychol. 15:1974;263-267.
2. Buccafusco J.J., Jackson W.J. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol. Aging. 12:1991;233-238.
3. Buccafusco J.J., Jackson W.J., Terry A.V. Jr., Marsh K.C., Decker M.W., Arneric S.P. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology. 120:1995;256-266.
4. Buccafusco J.J., Jackson W.J., Gattu M., Terry A.V. Jr. Isoarecolone-induced memory enhancement in monkeys: role of nicotinic receptors. NeuroReport. 6:1995;1223-1227.
5. Buccafusco J.J., Prendergast M., Terry A.V. Jr., Jackson W.J. Cognitive effects of cholinergic agonists in non-human primates. Drug Dev. Res. 38:1996;196-203.
6. Chiappeta L., Jarvik M.E. Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. Arch. Int. Pharmacodyn. Ther. 179:1969;161-166.
7. Clarke P.B.S. Nicotine and smoking: a perspective from animal studies. Psychopharmacology. 92:1987;135-143.
8. Costale B., Horovitz Z.P., Kelly M.E., Naylor R.J., Tomkins D.M. Ability of ACE inhibitors to improve basic performance and to antagonise scopolamine impairment in a mouse habituation test. Psychopharmacology. 98:1988;S11.
9. Currie D., Lewis R.V., McDevitt D.G., Nicholson A.N., Wright N.A. Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessment of mood. Br. J. Clin. Pharmacol. 30:1990;527-536.
10. Decker M.W., Majchrzak M.J. The effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology. 107:1992;530-534.
11. Deyo R.A., Straube K.T., Disterhoft J.F. Nimodipine facilitates associative learning in aging rabbits. Science. 243:1989;809-811.
12. Dimsdale J.E., Newton R.P., Joist T. Neuropsychological side effects of beta blockers. Arch. Int. Med. 149:1989;514-525.
13. Elias M.F., Robbins M.A., Schultz N.R., Streeten D.H.P. A longitudinal study of neuropsychological test performance for hypertensive and normotensive adults: initial findings. J. Gerontol. 41:1986;503-505.
14. Elias M.F., Robbins M.A., Schultz N.R.et al. Clinical significance of cognitive performance by hypertensive patients. Hypertension. 9:1987;192-197.
15. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J.C., White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am. J. Epidemiol. 138:1993;353-364.
16. Elrod K., Buccafusco J.J. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. J. Pharmacol. Biochem. Behav. 29:1988;15-21.
17. Elrod K., Buccafusco J.J., Jackson W.J. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 43:1988;277-287.
18. Elrod K., Buccafusco J.J. Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J. Pharmacol. Exp. Ther. 258:1991;403-409.
19. Farmer M.E., White L.R., Abbott R.D., Kittner S.J., Kaplan E., Wolz M.M., Brody J.A., Wolf P.A. Blood pressure and cognitive performance. Am. J. Epidemiol. 126:1987;1103-1114.
20. Fielder E.P., Marks M.J., Collins A.C. Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions. Int. J. Dev. Neurosci. 8:1990;533-540.
21. M. Gattu, J.R. Pauly, K.L. Boss, J.B. Summers, J.J. Buccafusco, Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part I, Brain Res. BRES 13807.
22. Hecht K., Poppei M., Hecht T., Postnow J.W., Moritz V., Baumann R. Lern- und Gedächtnissprozesse während der postnatalen Ontogonese von Ratten mit spontaner Hypertonie. Acta Biol. Med. Germ. 37:1978;1471-1478.
23. Hendley E.D., Atwater D.G., Myers M.M., Whitehorn D. Dissociation of genetic hyperactivity and hypertension in SHR rats. Hypertension. 5:1983;211-217.
24. Houston J.P., Schneider N.G., Jarvik M.E. Effects of smoking on free recall and organization. Am. J. Psychiatry. 135:1978;220-222.
25. Izqierdo I. Nimodipine and recovery of memory. Trends Pharmacol. Sci. 11:1990;309-310.
26. Jackson W.J., Buccafusco J.J. Nicotinic enhancement of delayed matching by monkeys is specific to the most difficult problems. Soc. Neurosci. Abstr. 15:1989;731.
27. W.J. Jackson, K. Elrod, J.J. Buccafusco, Delayed matching-to-sample in monkeys as a model for learning and memory deficits: role of brain nicotinic receptors, in: E.M. Meyer, J.W. Simpkins, J. Yamamoto (Eds.), Novel Approaches to the Treatment of Alzheimer's Disease, Plenum Press, New York, 1989, pp. 39-52.
28. Juskevich J.C., Robinson D.S., Whitehorn D. Effect of hypothalamic stimulation in spontaneously hypertensive and Wistar-Kyoto rats. Eur. J. Pharmacol. 51:1978;429-439.
29. Khan I.M., Printz M.P., Yakash T.L., Taylor P. Augmented response to intrathecal nicotinic agonists in spontaneous hypertension. Hypertension. 24:1994;611-619.
30. Knardahl S., Karlsen K. Passive-avoidance behavior of spontaneously hypertensive rats. Behav. Neural Biol. 42:1984;9-22.
31. Kubo T., Misu Y. Cardiovascular response to microinjection of physostigmine and choline into the dorsal medullary site of the rat. Neuropharmacology. 20:1981;1091-1095.
32. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
33. Madden D.J., Blumenthal J.A., Ekelund L.G. Effects of beta-blockade and exercise on cardiovascular and cognitive functioning. Hypertension. 11:1988;470-476.
34. Mondadori C., Etienne P. Nootropic effects of ACE-inhibitors in mice. Psychopharmacology. 100:1990;301-307.
35. Mori S., Kato M., Fujishima M. Impaired maze learning and cerebral glucose utilization in aged hypertensive rats. Hypertension. 25:1995;545-553.
36. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. J. Pharmacol. 2:1978;1457-1459.
37. Perry E.K., Perry R.H., Smith C.J., Dick D.J., Candy J.M., Edwardson J.A., Fairbairn A. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 50:1987;806-809.
38. Picciotto M.R., Zoll M., Lena C., Bessls A., Lallemand Y., LeNovere N., Vincent P., Pich E.M., Brulet P., Changeux J.-P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 274:1995;65-67.
39. Richardson P.J., Wyke M.A. Memory function: effects of different anti-hypertensive drugs. Drugs. 35:1988;80-85.
40. Salem S.A., McDevitt D.G. Central effects of beta-adrenoreceptor antagonists. Clin. Pharmacol. Ther. 33:1983;52-57.
41. Solomon S., Hotchkiss E., Saravay S.M., Bayer C., Ramsey P., Blum R.S. Impairment of memory function by antihypertensive medication. Arch. Gen. Psychiatry. 40:1983;1109-1112.
42. Stolerman I.P., Goldfarb T., Fink R., Jarvik M.E. Influence of cigarette smoking with nicotine antagonists. Psychopharmacology. 28:1973;247-259.
43. Sutterer P.J. Jr., DeVito W. Two-way shuttle box and lever-press avoidance in the spontaneously hypertensive and normotensive rat. J. Comp. Physiol. Psychol. 94:1980;155-163.
44. Warburton D.M., Wesnes K., Shergold K., James M. Facilitation of learning and state dependency with nicotine. Psychopharmacology. 89:1986;55-59.
45. Wesnes K., Warburton D.M., Matz B. Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology. 9:1983;41-44.
46. West R., Hack S. Effect of cigarettes on memory search and subjective ratings. Pharmacol. Biochem. Behav. 38:1991;281-286.
47. Whitehorn D., Atwater D.G., Low W.C., Gellis J.E., Hendley E.D. Independence of blood pressure and locomotor hyperactivity in normotensive and genetically hypertensive rats. Behav. Neural Biol. 37:1983;357-361.
48. Wyss J.M., Fisk G., Groen T.V. Impaired learning and memory in mature spontaneously hypertensive rats. Brain Res. 592:1992;135-140.
49. Yamada S., Kagawa Y., Ushijima H., Takayanagi N., Tomita T., Hayashi E. Brain nicotinic cholinoceptor binding in spontaneous hypertension. Brain Res. 410:1987;212-218.